Molecular dynamics of the ERRγ ligand-binding domain bound with agonist and inverse agonist
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0283364 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Santanu Sasidharan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, National Institute of Technology, Warangal, Telangana, India. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Drug Inverse Agonism. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Estrogen-related receptor gamma (ERRγ), the latest member of the ERR family, does not have any known reported natural ligands. Although the crystal structures of the apo, agonist-bound, and inverse agonist-bound ligand-binding domain (LBD) of ERRγ have been solved previously, their dynamic behavior has not been studied. Hence, to explore the intrinsic dynamics of the apo and ligand-bound forms of ERRγ, we applied long-range molecular dynamics (MD) simulations to the crystal structures of the apo and ligand-bound forms of the LBD of ERRγ. Using the MD trajectories, we performed hydrogen bond and binding free energy analysis, which suggested that the agonist displayed more hydrogen bonds with ERRγ than the inverse agonist 4-OHT. However, the binding energy of 4-OHT was higher than that of the agonist GSK4716, indicating that hydrophobic interactions are crucial for the binding of the inverse agonist. From principal component analysis, we observed that the AF-2 helix conformation at the C-terminal domain was similar to the initial structures during simulations, indicating that the AF-2 helix conformation is crucial with respect to the agonist or inverse agonist for further functional activity of ERRγ. In addition, we performed residue network analysis to understand intramolecular signal transduction within the protein. The betweenness centrality suggested that few of the amino acids are important for residue signal transduction in apo and ligand-bound forms. The results from this study may assist in designing better therapeutic compounds against ERRγ associated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, National Institute of Technology, Warangal, Telangana, India.
- Combinatorial Tumor Immunotherapy MRC, Chonnam National University Medical School, Hwasun-gun, Jeonnam, Republic of Korea.
- School of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu, Republic of Korea.
- Department of Animal Biotechnology, Jeonbuk National University, Jeonju, Republic of Korea.
- Department of Agricultural Convergence Technology, Jeonbuk National University, Jeonju, Republic of Korea.
ORCID-Profile: Santanu Sasidharan, Vijayakumar Gosu
Förderung
- National Research Foundation of Korea
Zitieren
APA
Sasidharan, S., Radhakrishnan, K., Lee, J. Y., Saudagar, P., Gosu, V., & Shin, D. (2023). Molecular dynamics of the ERRγ ligand-binding domain bound with agonist and inverse agonist. PLOS ONE. https://doi.org/10.1371/journal.pone.0283364
Vancouver
Sasidharan S, Radhakrishnan K, Lee JY, Saudagar P, Gosu V, Shin D. Molecular dynamics of the ERRγ ligand-binding domain bound with agonist and inverse agonist. PLOS ONE. 2023. doi:10.1371/journal.pone.0283364
BibTeX
@article{Sasidharan2023,
author = {Sasidharan, Santanu and Radhakrishnan, Kamalakannan and Lee, Jun-Yeong and Saudagar, Prakash and Gosu, Vijayakumar and Shin, Donghyun},
title = {Molecular dynamics of the ERRγ ligand-binding domain bound with agonist and inverse agonist},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0283364}
}
EUVIMED